临床疗效统计发现高KK-LC-1 mRNA表达的患者的OS(overall survival,总生存期)、DFS(disease-free survival,无病生存期)明显短于低KK-LC-1表达的患者(p<0.001),如图3所示。研究人员将KK-LC-1 高表达细胞系MDA-MB-231进行了基因敲除试验,把 MDA-MB-231/ NC(未敲除对照)和MDA-MB-231 / KD(敲除)细胞注射到...
Immunogen KK-LC-1 fusion protein Ag22619 种属同源性预测 Host / Isotype Rabbit / IgG Class Polyclonal Type Antibody Full Name chromosome X open reading frame 61 Synonyms Cancer/testis antigen 83, CT83, CXorf61, KK LC 1, KKLC1, KK-LC-1 Calculated Molecular Weight 13 kDa Observed Molecular...
25708-1-AP targets KK-LC-1 in WB, IHC, ELISA applications and shows reactivity with human, mouse samples. Tested Reactivity human, mouse Cited Reactivity human, mouse Host / Isotype Rabbit / IgG Class Polyclonal Type Antibody Immunogen KK-LC-1 fusion protein Ag22619 Predict reactive species ...
DescriptioN: Rabbit Polyclonal to KK-LC-1 N-epitope Applications: ELISA, IP, WB Reactivity: Human, Monkey 1 Publication
三阴性乳腺癌新靶点KK-LC-1 乳腺癌是各种癌症中发病率最高、死亡率第二高的恶性肿瘤。每年新增乳腺癌病例约占女性新增恶性肿瘤总数的30%,对女性健康构成极大威胁。 虽然乳腺癌症分子亚型的建立和综合治疗的出现大大提高了乳腺癌症患者的生存结局,但三阴性乳腺癌症具有异质性强、恶性程度高、预后较其他分子型差的...
本发明公开了一种KKLC1抗原靶向结合肽及其衍生物,探针与应用,KKLC1抗原靶向结合肽的序列为SEQ ID No.1:CKNTALTTC,其空间结构为环九肽,有9个氨基酸残基组成,且由首尾两端半胱氨酸形成二硫键连接,能够特异性地结合KKLC1抗原蛋白分子,亦可在体内,体外环境中结合KKLC1表达阳性的肿瘤细胞.经多水平,多对照的体内体...
Atlas高品质的PrecisA CT83单克隆抗体,近期在T-cure Bioscience公司主导的KK-LC-1肿瘤的I期临床研究中,扮演了关键角色。这一应用展现了Atlas产品的广泛适用性,不仅局限于基础科研,还能深入到体外诊断和药物研发领域。KK-LC-1作为癌胚系抗原,其在上皮癌中的表达显著增高,包括肺癌、胃癌、三阴性乳腺癌...
日前,Atlas郑重宣布,其生产的PrecisA 单克隆抗体Anti-CT83已被T-cure Bioscience公司用于临床Kita-Kyushu 肺癌抗原 1 (KK-LC-1) 的肿瘤的I期临床研究。这一事例表明Atlas的产品完全可以应用于IVD体外诊断和药物研发。 KK-LC-1是一种癌胚系(CG)抗原,在健康组织中表达量较低,但其在上皮癌中的表达显著增高,包括...
产品简介:人癌/睾丸抗原83抗原(KK-LC-1/CT83)检测试剂盒原理:用纯化的抗体包被微孔板,制成固相载体,往包被抗该指标抗体的微孔中依次加入标本或标准品、生物素化的抗该指标抗体、HRP标记的亲和素,经过彻底洗涤后用底物TMB显色。TMB在过氧化物酶的催化下转化成蓝色,并在酸的作用下转化成Z终的黄色。颜色的深浅...
In animal models, it has been verified that KK-LC-1 can promote tumor development in vivo [21]. In this study, we analyzed the relationship between the expression of KK-LC-1 and the prognosis of liver cancer patients by detecting the expression of KK-LC-1 and its corresponding antibodies...